Cargando…

Proteasomal cysteine deubiquitinase inhibitor b-AP15 suppresses migration and induces apoptosis in diffuse large B cell lymphoma

BACKGROUND: The first line therapy for patients with diffuse large B cell (DLBCL) is R-CHOP. About half of DLBCL patients are either refractory to, or will relapse, after the treatment. Therefore, identifying novel drug targets and effective therapeutic agents is urgently needed for improving DLBCL...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Liling, Sun, Yuening, Wang, Jinxiang, He, Qingyan, Chen, Xinmei, Lan, Xiaoying, Chen, Jinghong, Dou, Q. Ping, Shi, Xianping, Liu, Jinbao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836452/ https://www.ncbi.nlm.nih.gov/pubmed/31694672 http://dx.doi.org/10.1186/s13046-019-1446-y

Ejemplares similares

Inhibition of proteasomal deubiquitinases USP14 and UCHL5 overcomes tyrosine kinase inhibitor resistance in chronic myeloid leukaemia
por: Jiang, Liling, et al.
Publicado: (2022)

Inhibition of 19S proteasome-associated deubiquitinases by metal-containing compounds
por: Liu, Ningning, et al.
Publicado: (2015)

Metal-based proteasomal deubiquitinase inhibitors as potential anticancer agents
por: Chen, Xin, et al.
Publicado: (2017)

A novel deubiquitinase inhibitor b-AP15 triggers apoptosis in both androgen receptor-dependent and -independent prostate cancers
por: Cai, Jianyu, et al.
Publicado: (2017)

The proteasome deubiquitinase inhibitor b-AP15 enhances DR5 activation-induced apoptosis through stabilizing DR5
por: Oh, You-Take, et al.
Publicado: (2017)

Inhibitory Effect of b-AP15 on the 20S Proteasome
por: Huang, Li, et al.
Publicado: (2014)

Clinically used antirheumatic agent auranofin is a proteasomal deubiquitinase inhibitor and inhibits tumor growth
por: Liu, Ningning, et al.
Publicado: (2014)

Repurposing an antidandruff agent to treating cancer: zinc pyrithione inhibits tumor growth via targeting proteasome-associated deubiquitinases
por: Zhao, Chong, et al.
Publicado: (2017)

Oxidative Stress Induced by the Deubiquitinase Inhibitor b-AP15 Is Associated with Mitochondrial Impairment
por: Zhang, Xiaonan, et al.
Publicado: (2019)

Analysis of determinants for in vitro resistance to the small molecule deubiquitinase inhibitor b-AP15
por: Mofers, Arjan, et al.
Publicado: (2019)

The proteasome deubiquitinase inhibitor bAP15 downregulates TGF-β/Smad signaling and induces apoptosis via UCHL5 inhibition in ovarian cancer
por: Fukui, Shiho, et al.
Publicado: (2019)

A novel proteasome inhibitor suppresses tumor growth via targeting both 19S proteasome deubiquitinases and 20S proteolytic peptidases
por: Liu, Ningning, et al.
Publicado: (2014)

The Deubiquitinase Inhibitor b-AP15 and Its Effect on Phenotype and Function of Monocyte-Derived Dendritic Cells
por: Schmidt, Moritz, et al.
Publicado: (2019)

Deubiquitinase Inhibitor b-AP15 Attenuated LPS-Induced Inflammation via Inhibiting ERK1/2, JNK, and NF-Kappa B
por: Zhang, Fangcheng, et al.
Publicado: (2020)

Proteasome-associated deubiquitinases and cancer
por: Mofers, Arjan, et al.
Publicado: (2017)

Cyclin-dependent kinase 7/9 inhibitor SNS-032 induces apoptosis in diffuse large B-cell lymphoma cells
por: Jiang, Liling, et al.
Publicado: (2022)

Gambogic acid induces apoptosis in diffuse large B-cell lymphoma cells via inducing proteasome inhibition
por: Shi, Xianping, et al.
Publicado: (2015)

Bilirubin neurotoxicity is associated with proteasome inhibition
por: Huang, Hongbiao, et al.
Publicado: (2017)

Small-Molecule Inhibitors Targeting Proteasome-Associated Deubiquitinases
por: Moon, Seonghyeon, et al.
Publicado: (2021)

Regulation of Bax-dependent apoptosis by mitochondrial deubiquitinase USP30
por: Yan, Ding, et al.
Publicado: (2021)

Targeting Ubiquitin–Proteasome System With Copper Complexes for Cancer Therapy
por: Chen, Xin, et al.
Publicado: (2021)

Elevation of Proteasomal Substrate Levels Sensitizes Cells to Apoptosis Induced by Inhibition of Proteasomal Deubiquitinases
por: Sun, Chao, et al.
Publicado: (2014)

Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer
por: Xia, Xiaohong, et al.
Publicado: (2018)

Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor
por: Liao, Yuning, et al.
Publicado: (2017)

Broad Spectrum Deubiquitinase Inhibition Induces Both Apoptosis and Ferroptosis in Cancer Cells
por: Yang, Li, et al.
Publicado: (2020)

The Deubiquitinase USP29 Promotes SARS-CoV-2 Virulence by Preventing Proteasome Degradation of ORF9b
por: Gao, Wenying, et al.
Publicado: (2022)

Screen for ISG15-crossreactive Deubiquitinases
por: Catic, André, et al.
Publicado: (2007)

Atomic structure of the 26S proteasome lid reveals the mechanism of deubiquitinase inhibition
por: Dambacher, Corey M, et al.
Publicado: (2016)

Stabilization of MYC G-quadruplex DNA by ruthenium (II) complex overcomes imatinib resistance in chronic myeloid leukemia cells harboring T315I mutation
por: Sun, Yuening, et al.
Publicado: (2022)

Ubp6 deubiquitinase controls conformational dynamics and substrate degradation of the 26S proteasome
por: Bashore, Charlene, et al.
Publicado: (2015)

Deubiquitinase Ubp3 enhances the proteasomal degradation of key enzymes in sterol homeostasis
por: Lan, Qiuyan, et al.
Publicado: (2021)

Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo
por: Huang, Hongbiao, et al.
Publicado: (2015)

Deubiquitinase OTUD7B is a potential prognostic biomarker in diffuse large B-cell lymphoma
por: Qiu, Shi, et al.
Publicado: (2022)

Deubiquitinase activity is required for the proteasomal degradation of misfolded cytosolic proteins upon heat-stress
por: Fang, Nancy N., et al.
Publicado: (2016)

The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
por: Vdovin, Alexander, et al.
Publicado: (2022)

The Regulations of Deubiquitinase USP15 and Its Pathophysiological Mechanisms in Diseases
por: Chou, Chon-Kit, et al.
Publicado: (2017)

Entropic stabilization of a deubiquitinase provides conformational plasticity and slow unfolding kinetics beneficial for functioning on the proteasome
por: Lee, Yun-Tzai Cloud, et al.
Publicado: (2017)

Acute lymphoblastic leukemia cells are sensitive to disturbances in protein homeostasis induced by proteasome deubiquitinase inhibition
por: Mazurkiewicz, Magdalena, et al.
Publicado: (2017)

Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD
por: Komatsu, Kensei, et al.
Publicado: (2013)

The Ubp15 deubiquitinase promotes timely entry into S phase in Saccharomyces cerevisiae
por: Ostapenko, Denis, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_a8d23qk8t735omevr5o3g76hh7